Top Story

CRS: Congressional Review Act Eyed As Possible Tool To Erase 'Midnight' Rules By Obama Administration

Congress' research arm says some lawmakers are looking anew at a rarely used parliamentary tool, the Congressional Review Act, as a potential way for a new Congress and president to overturn regulations issued in the final months of the Obama administration.

Latest News

Under pressure to take sides, another wave of lawmakers and lobby groups announced Monday (May 2) either their support or opposition to CMS' proposed cost-cutting demonstration to change the physician reimbursement formula for administering drugs in Medicare Part B.

Key medical device lobby groups told FDA at a recent meeting that the agency's high-priority goals for the next user fee law don't match industry's, and said their members oppose the agency's real-world evidence funding plan and other proposals they believe are not worth the investment and don't fit into the scope of the user fee program, according to minutes from the March meeting.

The Alliance for Regenerative Medicine (ARM) says it won't support a bipartisan bill that would offer a five-year conditional approval for regenerative medicine products because the bill could lead to marketing of products that have not been proven to be safe and effective.

A bipartisan, bicameral group of 75 lawmakers is pushing the National Institutes of Health to adequately track whether children are being appropriately included in its clinical trials relevant to children's health, as directed by report language in the omnibus spending plan passed in December.

A conservative group behind state “right to try” laws says aggressive FDA reforms similar to those touted by GOP presidential candidate Ted Cruz are also needed to ease terminally ill patients’ access to unapproved but potentially life-saving therapies.

Senate Finance Chair Orrin Hatch (R-UT) expressed hope his committee would come up with mental health legislation by the end of the year, speaking at a hearing Thursday (April 28) where he and ranking Democrat Ron Wyden (OR) called for a closer look at mental health funding.

CMS is scaling back the federal exchange market's quality star ratings initiative from a full-fledged national program to a five-state pilot for the 2017 plan year, the agency said in new guidance and a related blog out Friday (April 29).

As CMS heralded the arrival of standardized plans on the federal exchange for 2017, congressional Republicans on Friday (April 29) questioned the move and asked that staff from key health care committees be briefed by May 13.